Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBGPN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,642
Award facts
- Contract value 100% obligated
- $25,641.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,641.90 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on September 23, 2025, with an ultimate completion date of September 24, 2025. This contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this delivery order part of the agency's ongoing pharmaceutical supply chain for military and federal healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Through this contract vehicle, the company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a critical vendor within the Defense Logistics Agency's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FBGPN?
SPE2DB25FBGPN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FBGPN worth?
The government has obligated $25,642 on SPE2DB25FBGPN.
Is contract SPE2DB25FBGPN an order under another contract?
Yes. SPE2DB25FBGPN is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGPN competed?
The extent of competition for SPE2DB25FBGPN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award